149 related articles for article (PubMed ID: 28616315)
1. Examined lymph node count in non-small-cell lung cancer: will it be a decision making approach in treatment of NSCLC?
Liu R; Chen J; Xu S
J Thorac Dis; 2017 May; 9(5):E480-E482. PubMed ID: 28616315
[No Abstract] [Full Text] [Related]
2. Negative Lymph Node Count Predicts Survival of Resected Non-small Cell Lung Cancer.
Zhou X; Wu C; Cheng Q
Lung; 2020 Oct; 198(5):839-846. PubMed ID: 32683563
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological characteristics and lymph node metastasis pathway of non-small-cell lung cancer located in the left lingular division.
Shien K; Toyooka S; Soh J; Okami J; Higashiyama M; Kadota Y; Maeda H; Hayama M; Chida M; Funaki S; Okumura M; Miyoshi S
Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):791-6. PubMed ID: 25805399
[TBL] [Abstract][Full Text] [Related]
4. The novel one-step nucleic acid amplification (OSNA) assay for the diagnosis of lymph node metastasis in patients with non-small cell lung cancer (NSCLC): Results of a multicenter prospective study.
Nakagawa K; Asamura H; Tsuta K; Nagai K; Yamada E; Ishii G; Mitsudomi T; Ito A; Higashiyama M; Tomita Y; Inoue M; Morii E; Matsuura N; Okumura M
Lung Cancer; 2016 Jul; 97():1-7. PubMed ID: 27237020
[TBL] [Abstract][Full Text] [Related]
5. New perspective to evaluate N1 staging: The peripheral lymph node metastasis status of non-small cell lung cancer.
Zhang J; Liu L; Wang G; Huang C; Chen Y; Zhang Y; Guo C; Li S
Thorac Cancer; 2019 Dec; 10(12):2253-2258. PubMed ID: 31617316
[TBL] [Abstract][Full Text] [Related]
6. Role of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Parameters and Extracellular Volume Fraction as Predictors of Lung Cancer Subtypes and Lymph Node Status in Non-Small-Cell Lung Cancer Patients.
Guo W; Lv B; Yang T; Tian M; Liu M; Lin X; Zhao P
J Cancer; 2023; 14(16):3108-3116. PubMed ID: 37859821
[No Abstract] [Full Text] [Related]
7. The current status of sentinel lymph node mapping in non-small cell lung cancer.
Minamiya Y; Ogawa J
Ann Thorac Cardiovasc Surg; 2005 Apr; 11(2):67-72. PubMed ID: 15900235
[TBL] [Abstract][Full Text] [Related]
8. Including positive lymph node count in the AJCC N staging may be a better predictor of the prognosis of NSCLC patients, especially stage III patients: a large population-based study.
Fan Y; Du Y; Sun W; Wang H
Int J Clin Oncol; 2019 Nov; 24(11):1359-1366. PubMed ID: 31183778
[TBL] [Abstract][Full Text] [Related]
9. Correlation study between flash dual source CT perfusion imaging and regional lymph node metastasis of non-small cell lung cancer.
Huang T; Sun H; Luo X; Zhang X; Jin K; Wang F; Sun L; Cheng N; Wu S; Lou Q; Li B
BMC Cancer; 2020 Jun; 20(1):547. PubMed ID: 32532248
[TBL] [Abstract][Full Text] [Related]
10. The value on SUV-derived parameters assessed on
Liao X; Liu M; Li S; Huang W; Guo C; Liu J; Xiong Y; Zhang J; Fan Y; Wang R
BMC Med Imaging; 2023 Apr; 23(1):49. PubMed ID: 37020286
[TBL] [Abstract][Full Text] [Related]
11. [Advances of mediastinal lymph node metastasis and the extent of lymph node
dissection in patients with stage T1 non-small cell lung cancer].
Ding N; Mao Y
Zhongguo Fei Ai Za Zhi; 2015 Jan; 18(1):34-41. PubMed ID: 25603871
[TBL] [Abstract][Full Text] [Related]
12. [Advances in Lymph Node Metastasis and the Modes of Lymph Node
Dissection in Early Stage Non-small Cell Lung Caner].
Ding N; Mao Y
Zhongguo Fei Ai Za Zhi; 2016 Jun; 19(6):359-63. PubMed ID: 27335297
[TBL] [Abstract][Full Text] [Related]
13. Different prognostic significance of examined lymph node count for patients with non-small-cell lung cancer ≤1 cm or >1-2 cm: a population-based study.
Liang Z; Wang X; Yang H; Fu H; Li M; Feng Z; Peng Z; Wang H
Future Oncol; 2020 Jan; 16(3):4497-4509. PubMed ID: 31845824
[No Abstract] [Full Text] [Related]
14. Expression of CXCR4 and VEGF-C is correlated with lymph node metastasis in non-small cell lung cancer.
Bi MM; Shang B; Wang Z; Chen G
Thorac Cancer; 2017 Nov; 8(6):634-641. PubMed ID: 28925100
[TBL] [Abstract][Full Text] [Related]
15. Intraoperative frozen sections of the regional lymph nodes contribute to surgical decision-making in non-small cell lung cancer patients.
Li W; Yang XN; Liao RQ; Nie Q; Dong S; Zhai HR; Wu YL; Zhong WZ
J Thorac Dis; 2016 Aug; 8(8):1974-80. PubMed ID: 27621849
[TBL] [Abstract][Full Text] [Related]
16. [Research for mediastinal lymph node desection style of stage Ib upper lobe non-small cell lung cancer].
Wang W; Mao F; Shen-Tu Y; Mei Y
Zhongguo Fei Ai Za Zhi; 2013 Nov; 16(11):584-90. PubMed ID: 24229624
[TBL] [Abstract][Full Text] [Related]
17. Lobe-specific lymph node dissection in early-stage non-small-cell lung cancer: An overview.
Peng L; Shang QW; Deng HY; Liu ZK; Li W; Wang Y
Asian J Surg; 2023 Feb; 46(2):683-687. PubMed ID: 35918226
[TBL] [Abstract][Full Text] [Related]
18. Association between VEGFR-3 expression and lymph node metastasis in non-small-cell lung cancer.
Li J; Yi H; Liu Z; Zhang H; Zhang D; Yue W; Jia H; Xu S; Li B
Exp Ther Med; 2015 Feb; 9(2):389-394. PubMed ID: 25574203
[TBL] [Abstract][Full Text] [Related]
19. Preoperative platelet count in predicting lymph node metastasis and prognosis in patients with non-small cell lung cancer.
Liu HB; Gu XL; Ma XQ; Lv TF; Wu Y; Xiao YY; Yuan DM; Li YF; Song Y
Neoplasma; 2013; 60(2):203-8. PubMed ID: 23259790
[TBL] [Abstract][Full Text] [Related]
20. Use of maximum standardized uptake value on fluorodeoxyglucose positron-emission tomography in predicting lymph node involvement in patients with primary non-small cell lung cancer.
Muto J; Hida Y; Kaga K; Ohtaka K; Okamoto S; Tamaki N; Nakada-Kubota R; Hirano S; Matsui Y
Anticancer Res; 2014 Feb; 34(2):805-10. PubMed ID: 24511016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
